Anavex Life Sciences Corp (AVXL)

[Amatuer17]

Ok - so you are writing this long posts based in what?

Few data points that company presented in 2 conf for 25 patients - 12 months - that entire data was minimal to say the least and inconclusive at best.

The outside experts who saw the data were not impressed - market was not impressed.

So much so that the company is cautious in saying anything - has not said that they will apply for fast track and/or breakthrough

There were few 6 patients that responded differently but that hasr happened in many drug trials fading later.

So what is the basis on which you are defending A2-73 as a drug that is going to succeed and change ALZ landscape?

Let's see how confident the company is - and when they decide to start P2/3?

Based on their lack of update - it seems they are still trying to figure out - how to talk about efficacy and decide about next trial design.